AG˹ٷ

STOCK TITAN

[144] LeMaitre Vascular, Inc. SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
144
Rhea-AI Filing Summary

LeMaitre Vascular (LMAT) submitted a Form 144 reporting a proposed sale of 939 shares of common stock with an aggregate market value of $87,784.39. The notice names Morgan Stanley Smith Barney LLC as broker and lists the approximate sale date as 08/08/2025 on NASDAQ, and shows 22,637,522 shares outstanding.

The filing states the securities were acquired on 08/08/2025 by a stock option exercise from the issuer and paid in cash. The section for securities sold in the past three months is marked "Nothing to Report". The form includes the standard attestation that the seller does not possess undisclosed material adverse information and references Rule 144 disclosure requirements.

LeMaitre Vascular (LMAT) ha depositato un Form 144 segnalando la proposta vendita di 939 azioni ordinarie per un valore di mercato complessivo di $87,784.39. L'avviso indica Morgan Stanley Smith Barney LLC come intermediario e riporta la data approssimativa di vendita 08/08/2025 su NASDAQ, mostrando 22,637,522 azioni in circolazione.

La denuncia dichiara che i titoli sono stati acquisiti il 08/08/2025 tramite esercizio di stock option dall'emittente e pagati in contanti. La sezione relativa ai titoli venduti negli ultimi tre mesi è contrassegnata come "Nothing to Report". Il modulo include l'attestazione standard che il venditore non possiede informazioni materiali sfavorevoli non divulgate e fa riferimento ai requisiti di disclosure previsti dalla Rule 144.

LeMaitre Vascular (LMAT) presentó un Formulario 144 notificando una propuesta de venta de 939 acciones ordinarias con un valor de mercado agregado de $87,784.39. El aviso nombra a Morgan Stanley Smith Barney LLC como corredor y señala la fecha aproximada de venta como 08/08/2025 en NASDAQ, y muestra 22,637,522 acciones en circulación.

La presentación indica que los valores se adquirieron el 08/08/2025 mediante un ejercicio de opciones sobre acciones del emisor y se pagaron en efectivo. La sección sobre valores vendidos en los últimos tres meses está marcada "Nothing to Report". El formulario incluye la declaración estándar de que el vendedor no posee información material adversa no divulgada y hace referencia a los requisitos de divulgación de la Rule 144.

LeMaitre Vascular (LMAT)Form 144� 제출하여 � 시가가 $87,784.39939주의 보통� 판매 예정 사실� 신고했습니다. 공지� 중개인으� Morgan Stanley Smith Barney LLC� 명시하고, 예상 판매일을 08/08/2025NASDAQ� 기재했으�, 발행 주식 수 22,637,522주로 나와 있습니다.

신고서에� 해당 증권� 발행인으로부� 08/08/2025주식매수선택� 행사� 취득되어 ˳금으로 지급되었음� 기재되어 있습니다. 지� 3개월 동안 판매� 증권란은 "Nothing to Report"� 표시되어 있습니다. 양식에 판매자가 공개되지 않은 중대� 불리� 정보� 보유하고 있지 않다� 표준 확인서가 포함되어 있으� Rule 144� 공시 요건� 참고하고 있습니다.

LeMaitre Vascular (LMAT) a déposé un Form 144 déclarant la vente proposée de 939 actions ordinaires pour une valeur de marché totale de $87,784.39. L'avis nomme Morgan Stanley Smith Barney LLC comme courtier et indique la date approximative de vente au 08/08/2025 sur le NASDAQ, et fait état de 22,637,522 actions en circulation.

Le dépôt indique que les titres ont été acquis le 08/08/2025 par un exercice d'options sur actions de l'émetteur et payés en Գܳé. La rubrique relative aux titres vendus au cours des trois derniers mois est marquée "Nothing to Report". Le formulaire contient l'attestation standard selon laquelle le vendeur ne possède pas d'informations défavorables importantes non divulguées et fait référence aux obligations de divulgation de la Rule 144.

LeMaitre Vascular (LMAT) reichte ein Form 144 ein und meldete einen geplanten Verkauf von 939 Stammaktien mit einem gesamten Marktwert von $87,784.39. Die Mitteilung nennt Morgan Stanley Smith Barney LLC als Broker und gibt das ungefähre Verkaufsdatum mit 08/08/2025 an der NASDAQ an und weist 22,637,522 ausstehende Aktien aus.

Die Einreichung besagt, dass die Wertpapiere am 08/08/2025 durch Ausübung von Aktienoptionen des Emittenten erworben und in Bargeld bezahlt wurden. Der Abschnitt für in den letzten drei Monaten verkaufte Wertpapiere ist mit "Nothing to Report" markiert. Das Formular enthält die übliche Versicherung, dass der Verkäufer keine nicht offengelegten wesentlichen nachteiligen Informationen besitzt, und verweist auf die Offenlegungspflichten gemäß Rule 144.

Positive
  • None.
Negative
  • None.

Insights

TL;DR: Routine Rule 144 notice for 939 shares acquired by option exercise; no recent disposals reported—unlikely to be market-moving.

The filing documents a proposed sale of 939 common shares with an aggregate value of $87,784.39 and lists Morgan Stanley Smith Barney LLC as the broker for an expected NASDAQ sale on 08/08/2025. The seller reports acquisition by stock option exercise and payment in cash, and the filing shows "Nothing to Report" for sales in the past three months. Based solely on the disclosure, this appears to be an ordinary insider/affiliate liquidation notice under Rule 144 rather than a material corporate development.

TL;DR: Disclosure complies with Rule 144 formalities and includes the attestation about material nonpublic information; identification fields in the excerpt are limited.

The document includes the required attestation that the person for whose account securities will be sold does not know material adverse information and references 10b5-1 trading plan disclosure language. The provided excerpt shows broker details and transaction mechanics (option exercise, cash payment) but does not present identifying details for the seller in the visible text. From a governance and compliance perspective, the form records the necessary transaction facts but the excerpted content limits visibility into the filer identity and broader context.

LeMaitre Vascular (LMAT) ha depositato un Form 144 segnalando la proposta vendita di 939 azioni ordinarie per un valore di mercato complessivo di $87,784.39. L'avviso indica Morgan Stanley Smith Barney LLC come intermediario e riporta la data approssimativa di vendita 08/08/2025 su NASDAQ, mostrando 22,637,522 azioni in circolazione.

La denuncia dichiara che i titoli sono stati acquisiti il 08/08/2025 tramite esercizio di stock option dall'emittente e pagati in contanti. La sezione relativa ai titoli venduti negli ultimi tre mesi è contrassegnata come "Nothing to Report". Il modulo include l'attestazione standard che il venditore non possiede informazioni materiali sfavorevoli non divulgate e fa riferimento ai requisiti di disclosure previsti dalla Rule 144.

LeMaitre Vascular (LMAT) presentó un Formulario 144 notificando una propuesta de venta de 939 acciones ordinarias con un valor de mercado agregado de $87,784.39. El aviso nombra a Morgan Stanley Smith Barney LLC como corredor y señala la fecha aproximada de venta como 08/08/2025 en NASDAQ, y muestra 22,637,522 acciones en circulación.

La presentación indica que los valores se adquirieron el 08/08/2025 mediante un ejercicio de opciones sobre acciones del emisor y se pagaron en efectivo. La sección sobre valores vendidos en los últimos tres meses está marcada "Nothing to Report". El formulario incluye la declaración estándar de que el vendedor no posee información material adversa no divulgada y hace referencia a los requisitos de divulgación de la Rule 144.

LeMaitre Vascular (LMAT)Form 144� 제출하여 � 시가가 $87,784.39939주의 보통� 판매 예정 사실� 신고했습니다. 공지� 중개인으� Morgan Stanley Smith Barney LLC� 명시하고, 예상 판매일을 08/08/2025NASDAQ� 기재했으�, 발행 주식 수 22,637,522주로 나와 있습니다.

신고서에� 해당 증권� 발행인으로부� 08/08/2025주식매수선택� 행사� 취득되어 ˳금으로 지급되었음� 기재되어 있습니다. 지� 3개월 동안 판매� 증권란은 "Nothing to Report"� 표시되어 있습니다. 양식에 판매자가 공개되지 않은 중대� 불리� 정보� 보유하고 있지 않다� 표준 확인서가 포함되어 있으� Rule 144� 공시 요건� 참고하고 있습니다.

LeMaitre Vascular (LMAT) a déposé un Form 144 déclarant la vente proposée de 939 actions ordinaires pour une valeur de marché totale de $87,784.39. L'avis nomme Morgan Stanley Smith Barney LLC comme courtier et indique la date approximative de vente au 08/08/2025 sur le NASDAQ, et fait état de 22,637,522 actions en circulation.

Le dépôt indique que les titres ont été acquis le 08/08/2025 par un exercice d'options sur actions de l'émetteur et payés en Գܳé. La rubrique relative aux titres vendus au cours des trois derniers mois est marquée "Nothing to Report". Le formulaire contient l'attestation standard selon laquelle le vendeur ne possède pas d'informations défavorables importantes non divulguées et fait référence aux obligations de divulgation de la Rule 144.

LeMaitre Vascular (LMAT) reichte ein Form 144 ein und meldete einen geplanten Verkauf von 939 Stammaktien mit einem gesamten Marktwert von $87,784.39. Die Mitteilung nennt Morgan Stanley Smith Barney LLC als Broker und gibt das ungefähre Verkaufsdatum mit 08/08/2025 an der NASDAQ an und weist 22,637,522 ausstehende Aktien aus.

Die Einreichung besagt, dass die Wertpapiere am 08/08/2025 durch Ausübung von Aktienoptionen des Emittenten erworben und in Bargeld bezahlt wurden. Der Abschnitt für in den letzten drei Monaten verkaufte Wertpapiere ist mit "Nothing to Report" markiert. Das Formular enthält die übliche Versicherung, dass der Verkäufer keine nicht offengelegten wesentlichen nachteiligen Informationen besitzt, und verweist auf die Offenlegungspflichten gemäß Rule 144.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

Lemaitre Vasculr

NASDAQ:LMAT

LMAT Rankings

LMAT Latest News

LMAT Latest SEC Filings

LMAT Stock Data

2.16B
20.81M
8.08%
95.13%
5.88%
Medical Instruments & Supplies
Surgical & Medical Instruments & Apparatus
United States
BURLINGTON